Literature DB >> 3085298

Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients.

A Zeevi, J Fung, T R Zerbe, C Kaufman, B S Rabin, B P Griffith, R L Hardesty, R J Duquesnoy.   

Abstract

Studies were conducted to determine the functional characteristics of lymphocytes infiltrating human heart allografts. We have developed methodologies to generate lymphocyte cultures from endomyocardial biopsies. Thirteen biopsies from four heart transplant recipients, obtained at different days during a posttransplant period of less than two months, were cultured in interleukin-2 (IL-2)-containing medium supplemented with irradiated autologous peripheral blood lymphocytes as feeder cells. Lymphocyte cultures were obtained from all 13 biopsies and they exhibited a proliferative response to IL-2, suggesting the presence of activated T cells that express IL-2 receptors. Several cultures consisted of Leu 3 (helper/inducer) T cells, whereas others were primarily Leu 2 (cytotoxic/suppressor) T cells or a mixture of both types of cells. Cultured lymphocytes were also shown to be able to undergo secondary proliferation to donor-specific leukocytes as measured by primed lymphocyte testing (PLT). The PLT specificity of these cells was frequently toward class II HLA antigens of the donor, but certain cultures had PLT specificity associated with class I HLA antigens. These results demonstrate the feasibility of growing functionally active T cells from heart transplant biopsies. An analysis of the phenotypes and allospecificity, as well as a functional characterization of these cells, should generate useful information about the types of T cells involved in cardiac transplant rejection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3085298     DOI: 10.1097/00007890-198605000-00014

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  18 in total

1.  Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.

Authors:  A C Tsamandas; S M Pham; E C Seaberg; O Pappo; R L Kormos; A Kawai; B P Griffith; A Zeevi; R Duquesnoy; J J Fung; T E Starzl; A J Demetris
Journal:  J Heart Lung Transplant       Date:  1997-07       Impact factor: 10.247

2.  Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection.

Authors:  A Zeevi; G Eiras; C Kaufman; M Alessiani; A J Demetris; K Abu-Elmagd; A Jain; V Warty; R Venkataramanan; G Burckart
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Acute rejection in heart transplant patients is associated with the presence of committed donor-specific cytotoxic lymphocytes in the graft but not in the blood.

Authors:  L M Vaessen; C C Baan; A J Ouwehand; N H Jutte; A H Balk; B Mochtar; F H Claas; W Weimar
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

4.  In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs.

Authors:  A Zeevi; R Duquesnoy; G Eiras; H Rabinowich; S Todo; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1988-02-01       Impact factor: 1.066

5.  Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.

Authors:  A Zeevi; R Duquesnoy; G Eiras; H Rabinowich; S Todo; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

6.  Adherence of alloreactive lymphocytes to human arterial endothelial cell monolayers.

Authors:  Y L Colson; B H Markus; A Zeevi; R J Duquesnoy
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

Review 7.  Heart transplantation: cellular and humoral immunity.

Authors:  M L Rose; M H Yacoub
Journal:  Springer Semin Immunopathol       Date:  1989

8.  Functional characterization of infiltrating T lymphocytes in human hepatic allografts.

Authors:  J J Fung; A Zeevi; T E Starzl; J Demetris; S Iwatsuki; R J Duquesnoy
Journal:  Hum Immunol       Date:  1986-06       Impact factor: 2.850

9.  Immune status of recipients following bone marrow-augmented solid organ transplantation.

Authors:  A Zeevi; M Pavlick; S Lombardozzi; R Banas; O Pappo; A S Rao; P Fontes; J Demetris; R Shapiro; F Dodson
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

10.  Cardiac transplantation. Emerging from an experiment to a service.

Authors:  B P Griffith; R L Hardesty; A Trento; R L Kormos; H T Bahnson
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.